Elutia Inc (ELUT)
3.79
+0.60
(+18.81%)
USD |
NASDAQ |
Nov 04, 16:00
3.72
-0.07
(-1.85%)
After-Hours: 20:00
Elutia Research and Development Expense (TTM): 4.113M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.113M |
| March 31, 2024 | 3.981M |
| December 31, 2023 | 4.40M |
| September 30, 2023 | 4.877M |
| June 30, 2023 | 6.043M |
| March 31, 2023 | 7.791M |
| December 31, 2022 | 8.472M |
| September 30, 2022 | 9.988M |
| June 30, 2022 | 10.55M |
| Date | Value |
|---|---|
| March 31, 2022 | 9.818M |
| December 31, 2021 | 9.266M |
| September 30, 2021 | 7.863M |
| June 30, 2021 | 6.838M |
| March 31, 2021 | 6.365M |
| December 31, 2020 | 5.954M |
| September 30, 2020 | 4.639M |
| June 30, 2020 | 3.882M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.882M
Minimum
Jun 2020
10.55M
Maximum
Jun 2022
6.756M
Average
6.365M
Median
Mar 2021
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |